These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells. Telang NT; Narayanan R; Bradlow HL; Osborne MP Breast Cancer Res Treat; 1991 Aug; 18(3):155-63. PubMed ID: 1756258 [TBL] [Abstract][Full Text] [Related]
4. Alteration in proliferative and endocrine responsiveness of human mammary carcinoma cells by prototypic tumor-suppressing agents. Suto A; Bradlow HL; Kubota T; Kitajima M; Wong GY; Osborne MP; Telang NT Steroids; 1993 May; 58(5):215-9. PubMed ID: 8356573 [TBL] [Abstract][Full Text] [Related]
5. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT Breast Cancer Res Treat; 1993 Sep; 27(3):193-202. PubMed ID: 8312577 [TBL] [Abstract][Full Text] [Related]
6. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. Telang NT; Suto A; Wong GY; Osborne MP; Bradlow HL J Natl Cancer Inst; 1992 Apr; 84(8):634-8. PubMed ID: 1556774 [TBL] [Abstract][Full Text] [Related]
7. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors. Katdare M; Singhal H; Newmark H; Osborne MP; Telang NT Cancer Lett; 1997 Jan; 111(1-2):141-7. PubMed ID: 9022139 [TBL] [Abstract][Full Text] [Related]
9. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Medina D; Kittrell FS; Oborn CJ; Schwartz M Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201 [TBL] [Abstract][Full Text] [Related]
10. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Han BS; Fukamachi K; Takasuka N; Ohnishi T; Maeda M; Yamasaki T; Tsuda H Carcinogenesis; 2002 Jul; 23(7):1209-15. PubMed ID: 12117780 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145 [TBL] [Abstract][Full Text] [Related]
13. Hormone sensitivity in vitro and in vivo of v-ras-transfected MCF-7 cell derivatives. Van Roy F; Mareel M; Vleminckx K; Beyaert R; Fiers W; Devleeschouwer N; Muquardt C; Legros N; Bracke M; Leclercq G Int J Cancer; 1990 Sep; 46(3):522-32. PubMed ID: 2203690 [TBL] [Abstract][Full Text] [Related]
14. Oncogenes, estradiol biotransformation, and mammary carcinogenesis. Telang NT Ann N Y Acad Sci; 1996 Apr; 784():277-87. PubMed ID: 8651576 [No Abstract] [Full Text] [Related]
15. Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture. Nishizawa Y; Sato B; Miyashita Y; Tsukada S; Hirose T; Kishimoto S; Matsumoto K Endocrinology; 1988 Jan; 122(1):227-35. PubMed ID: 3275537 [TBL] [Abstract][Full Text] [Related]
16. Expression of the oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells. Günzburg WH; Salmons B; Schlaeffli A; Moritz-Legrand S; Jones W; Sarkar NH; Ullrich R Carcinogenesis; 1988 Oct; 9(10):1849-56. PubMed ID: 3048764 [TBL] [Abstract][Full Text] [Related]
17. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions. Pontiggia O; Rodriguez V; Fabris V; Raffo D; Bumaschny V; Fiszman G; de Kier Joffé EB; Simian M Breast Cancer Res Treat; 2009 Jul; 116(2):247-55. PubMed ID: 18622696 [TBL] [Abstract][Full Text] [Related]
18. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells. Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203 [TBL] [Abstract][Full Text] [Related]
19. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention. Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512 [TBL] [Abstract][Full Text] [Related]
20. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone. Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]